Absci Corporation (ABSI)
NASDAQ: ABSI · Real-Time Price · USD
10.89
+0.68 (6.66%)
At close: Jun 26, 2026, 4:00 PM EDT
10.98
+0.09 (0.83%)
After-hours: Jun 26, 2026, 7:59 PM EDT
Absci Employees
Absci had 140 employees as of December 31, 2025. The number of employees decreased by 17 or -10.83% compared to the previous year.
Employees
140
Change (1Y)
-17
Growth (1Y)
-10.83%
Revenue / Employee
$13,114
Profits / Employee
-$845,971
Market Cap
1.84B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Fortrea Holdings | 14,000 |
| Sarepta Therapeutics | 835 |
| Vir Biotechnology | 367 |
| UroGen Pharma | 298 |
| Zymeworks | 243 |
| Zenas BioPharma | 167 |
| Innoviva | 159 |
| Septerna | 130 |
ABSI News
- 1 day ago - Healthcare stocks have become a haven for investors ditching tech - Market Watch
- 2 days ago - Absci price target raised to $10 from $4.10 at Morgan Stanley - TheFly
- 2 days ago - Absci price target raised to $16 from $8 at H.C. Wainwright - TheFly
- 3 days ago - Absci prices 13.5M shares at $7.41 in public offering - TheFly
- 3 days ago - Absci reports Phase 1 data from human trial of ABS-201 - TheFly
- 3 days ago - Absci Announces Pricing of $100 Million Underwritten Offering with Leading Strategic and Financial Investors - GlobeNewsWire
- 3 days ago - Absci Announces Positive Interim Phase 1 Data from the HEADLINE™ Trial of ABS-201, a Novel Antibody Targeting the Prolactin Receptor (PRLR) - GlobeNewsWire
- 12 days ago - Absci price target raised to $15 from $10 at Guggenheim - TheFly